{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:13:11Z","timestamp":1790374391334,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":45,"publisher":"Springer New York","isbn-type":[{"value":"9781493991501","type":"print"},{"value":"9781493991518","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-9151-8_9","type":"book-chapter","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T17:11:58Z","timestamp":1550509918000},"page":"199-228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR"],"prefix":"10.1007","author":[{"given":"Christiane","family":"Pott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Ritgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent H. J.","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques J. M.","family":"van Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kneba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,19]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.bbmt.2007.05.012","volume":"13","author":"JR Brown","year":"2007","unstructured":"Brown JR, Feng Y, Gribben JG, Neuberg D, Fisher DC, Mauch P, Nadler LM, Freedman AS (2007) Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission. Biol Blood Marrow Transplant 13:1057\u20131065","journal-title":"Biol Blood Marrow Transplant"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"6094","DOI":"10.1200\/JCO.2009.22.6258","volume":"27","author":"L Goff","year":"2009","unstructured":"Goff L, Summers K, Iqbal S, Kuhlmann J, Kunz M, Louton T, Hagenbeek A, Morschhauser F, Putz B, Lister A, Rohatiner A (2009) Quantitative PCR analysis for Bcl-2\/IgH in a phase III study of yttrium-90 ibritumomab tiuxetan as consolidation of first remission in patients with follicular lymphoma. J Clin Oncol 27:6094\u20136100","journal-title":"J Clin Oncol"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1365-2141.2008.07101.x","volume":"141","author":"C Hirt","year":"2008","unstructured":"Hirt C, Schuler F, Kiefer T, Schwenke C, Haas A, Niederwieser D, Neser S, Assmann M, Srock S, Rohrberg R, Dachselt K, Leithauser M, Rabkin CS, Herold M, Dolken G (2008) Rapid and sustained clearance of circulating lymphoma cells after chemotherapy plus rituximab: clinical significance of quantitative t(14;18) PCR monitoring in advanced stage follicular lymphoma patients. BrJ Haematol 141:631\u2013640","journal-title":"BrJ Haematol"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.1158\/1078-0432.CCR-14-0407","volume":"20","author":"S Galimberti","year":"2014","unstructured":"Galimberti S, Luminari S, Ciabatti E, Grassi S, Guerrini F, Dondi A, Marcheselli L, Ladetto M, Piccaluga PP, Gazzola A, Mannu C, Monitillo L, Mantoan B, Del Giudice I, Della Starza I, Cavalli M, Arcaini L, Tucci A, Palumbo GA, Rigacci L, Pulsoni A, Vitolo U, Boccomini C, Vallisa D, Bertoldero G, Gaidano G, Musto P, Petrini M, Federico M (2014) Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial. Clin Cancer Res 20:6398\u20136405","journal-title":"Clin Cancer Res"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1182\/blood-2013-06-507319","volume":"122","author":"M Ladetto","year":"2013","unstructured":"Ladetto M, Lobetti-Bodoni C, Mantoan B, Ceccarelli M, Boccomini C, Genuardi E, Chiappella A, Baldini L, Rossi G, Pulsoni A, Di Raimondo F, Rigacci L, Pinto A, Galimberti S, Bari A, Rota-Scalabrini D, Ferrari A, Zaja F, Gallamini A, Specchia G, Musto P, Rossi FG, Gamba E, Evangelista A, Vitolo U (2013) Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program. Blood 122:3759\u20133766","journal-title":"Blood"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1182\/blood-2007-10-116749","volume":"111","author":"M Ladetto","year":"2008","unstructured":"Ladetto M, De Marco F, Benedetti F, Vitolo U, Parti C, Rambaldi A, Pulsoni A, Musso M, Liberati AM, Olivieri A, Gallamini A, Pogliani E, Scalabrini DR, Callea V, Di Raimondo F, Pavone V, Tucci A, Cortelazzo S, Levis A, Boccadoro M, Majolino I, Pileri A, Gianni AM, Passera R, Corradini P, Tarella C (2008) Prospective, multicenter randomized GITMO\/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall surviva. Blood 111:4004\u20134013","journal-title":"Blood"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1182\/blood-2004-06-2490","volume":"105","author":"A Rambaldi","year":"2005","unstructured":"Rambaldi A, Carlotti E, Oldani E, Della Starza I, Baccarani M, Cortelazzo S, Lauria F, Arcaini L, Morra E, Pulsoni A, Rigacci L, Rupolo M, Zaja F, Zinzani PL, Barbui T, Foa R (2005) Quantitative PCR of bone marrow BCL2\/IgH positive cells at diagnosis predicts treatment response and long-term outcome in Follicular non Hodgkin\u2019s Lymphoma. Blood 105:3428\u20133433","journal-title":"Blood"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1365-2141.2012.09174.x","volume":"158","author":"CH Geisler","year":"2012","unstructured":"Geisler CH, Kolstad A, Laurell A, Jerkeman M, R\u00e4ty R, Andersen NS, Pedersen LB, Eriksson M, Nordstr\u00f6m M, Kimby E, Bentzen H, Kuittinen O, Lauritzsen GF, Nilsson-Ehle H, Ralfkiaer E, Ehinger M, Sundstr\u00f6m C, Delabie J, Karjalainen-Lindsberg ML, Brown P, Elonen E, Nordic Lymphoma Group (2012) Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur. Br J Haematol 158:355\u2013362","journal-title":"Br J Haematol"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(16)00739-X","volume":"388","author":"O Hermine","year":"2016","unstructured":"Hermine O, Hoster E, Walewski J, Bosly A, Stilgenbauer S, Thieblemont C, Szymczyk M, Bouabdallah R, Kneba M, Hallek M, Salles G, Feugier P, Ribrag V, Birkmann J, Forstpointner R, Haioun C, H\u00e4nel M, Casasnovas RO, Finke J, Peter N, Bouabdallah K, Sebban C, Fischer T, D\u00fchrsen U, Metzner B, Maschmeyer G, Kanz L, Schmidt C, Delarue R, Brousse N, Klapper W, Macintyre E, Delfau-Larue M-H, Pott C, Hiddemann W, Unterhalt M, Dreyling M (2016) Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma N. Lancet 388:565\u2013575","journal-title":"Lancet"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1182\/blood-2005-07-2845","volume":"107","author":"C Pott","year":"2006","unstructured":"Pott C, Schrader C, Gesk S, Harder L, Tiemann M, Raff T, Bruggemann M, Ritgen M, Gahn B, Unterhalt M, Dreyling M, Hiddemann W, Siebert R, Dreger P, Kneba M (2006) Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma. Blood 107:2271\u20132278","journal-title":"Blood"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1182\/blood-2009-06-230250","volume":"115","author":"C Pott","year":"2010","unstructured":"Pott C, Hoster E, Delfau-Larue MH, Beldjord K, Bottcher S, Asnafi V, Plonquet A, Siebert R, Callet-Bauchu E, Andersen N, van Dongen JJ, Klapper W, Berger F, Ribrag V, van Hoof AL, Trneny M, Walewski J, Dreger P, Unterhalt M, Hiddemann W, Kneba M, Kluin-Nelemans HC, Hermine O, Macintyre E, Dreyling M (2010) Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study. Blood 115:3215\u20133223","journal-title":"Blood"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1200\/JCO.2013.52.2466","volume":"32","author":"E Hoster","year":"2014","unstructured":"Hoster E, Klapper W, Hermine O, Kluin-Nelemans HC, Walewski J, Van HA, Trneny M, Geisler CH, Di RF, Szymczyk M, Stilgenbauer S, Thieblemont C, Hallek M, Forstpointner R, Pott C, Ribrag V, Doorduijn J, Hiddemann W, Dreyling MH, Unterhalt M (2014) Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network. JClinOncol 32:1338\u20131346","journal-title":"JClinOncol"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1182\/blood-2004-06-2490","volume":"105","author":"A Rambaldi","year":"2005","unstructured":"Rambaldi A, Carlotti E, Oldani E, Della Starza I, Baccarani M, Cortelazzo S, Lauria F, Arcaini L, Morra E, Pulsoni A, Rigacci L, Rupolo M, Zaja F, Zinzani PL, Barbui T, Foa R (2005) Quantitative PCR of bone marrow BCL2\/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma. Blood 105:3428\u20133433","journal-title":"Blood"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1046\/j.1365-2141.2002.03448.x","volume":"117","author":"C Voena","year":"2002","unstructured":"Voena C, Locatelli G, Castellino C, Omede P, Ladetto M, Zappone E, Milani R, Perfetti V, Boccadoro M, Pileri A, Lusso P, Villa C, Malnati M, Corradini P (2002) Qualitative and quantitative polymerase chain reaction detection of the residual myeloma cell contamination after positive selection of CD34+ cells with small- and large-scale Miltenyi cell sorting system. Br J Haematol 117:642\u2013645","journal-title":"Br J Haematol"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1182\/blood-2002-02-0621","volume":"100","author":"M Ladetto","year":"2002","unstructured":"Ladetto M, Corradini P, Vallet S, Benedetti F, Vitolo U, Martelli M, Brugiatelli M, Coser P, Perrotti A, Majolino I, Fioritoni G, Morandi S, Musso M, Zambello R, Chisesi T, Di Renzo N, Vivaldi P, De Crescenzo A, Gallamini A, Salvi F, Santini G, Boccomini C, Sorio M, Astolfi M, Drandi D, Pileri A, Tarella C (2002) High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Blood 100:1559\u20131565","journal-title":"Blood"},{"key":"9_CR16","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1182\/blood.V90.10.4212","volume":"90","author":"NS Andersen","year":"1997","unstructured":"Andersen NS, Donovan JW, Borus JS, Poor CM, Neuberg D, Aster JC, Nadler LM, Freedman AS, Gribben JG (1997) Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease. Blood 90:4212\u20134221","journal-title":"Blood"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/sj.leu.2404467","volume":"21","author":"JHJM Krieken van","year":"2007","unstructured":"van Krieken JHJM, Langerak AW, Macintyre EA, Kneba M, Hodges E, Sanz RG, Morgan GJ, Parreira A, Molina TJ, Cabe\u00e7adas J, Gaulard P, Jasani B, Garcia JF, Ott M, Hannsmann ML, Berger F, Hummel M, Davi F, Br\u00fcggemann M, Lavender FL, Schuuring E, Evans PAS, White H, Salles G, Groenen PJTA, Gameiro P, Pott C, Van Dongen JJM (2007) Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 21:201\u2013206","journal-title":"Leukemia"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-2141.2011.08803.x","volume":"155","author":"K Payne","year":"2011","unstructured":"Payne K, Wright P, Grant JW, Huang Y, Hamoudi R, Bacon CM, Du MQ, Liu H (2011) BIOMED-2 PCR assays for IGK gene rearrangements are essential for B-cell clonality analysis in follicular lymphoma. Br J Haematol 155:84\u201392","journal-title":"Br J Haematol"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/bjh.14616","volume":"177","author":"M Cavalli","year":"2017","unstructured":"Cavalli M, De Novi LA, Della I, Cappelli LV, Nunes V, Pulsoni A, Del Giudice I, Guarini A, Fo R (2017) Comparative analysis between RQ-PCR and digital droplet PCR of BCL2\/IGH gene rearrangement in the peripheral blood and bone marrow of early stage follicular lymphoma. Br J Haematol 177:588\u2013596","journal-title":"Br J Haematol"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jmoldx.2015.05.007","volume":"17","author":"D Drandi","year":"2015","unstructured":"Drandi D, Kubiczkova-besse L, Ferrero S, Dani N, Passera R, Mantoan B, Gambella M, Monitillo L, Saraci E, Ghione P, Genuardi E, Barbero D, Omed\u00e8 P, Barberio D, Hajek R, Vitolo U, Palumbo A, Cortelazzo S, Boccadoro M, Inghirami G, Ladetto M (2015) Minimal residual disease detection by droplet digital PCR in multiple myeloma, mantle cell lymphoma, and follicular lymphoma: a comparison with real-time PCR. J Mol Diagn 17:652\u2013660","journal-title":"J Mol Diagn"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/sj.leu.2404479","volume":"21","author":"PA Evans","year":"2007","unstructured":"Evans PA, Pott C, Groenen PJ, Salles G, Davi F, Berger F, Garcia JF, van Krieken JH, Pals S, Kluin P, Schuuring E, Spaargaren M, Boone E, Gonzalez D, Martinez B, Villuendas R, Gameiro P, Diss TC, Mills K, Morgan GJ, Carter GI, Milner BJ, Pearson D, Hummel M, Jung W, Ott M, Canioni D, Beldjord K, Bastard C, Delfau-Larue MH, van Dongen JJ, Molina TJ, Cabecadas J (2007) Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 21:207\u2013214","journal-title":"Leukemia"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJ Dongen van","year":"2003","unstructured":"van Dongen JJ, Langerak AW, Br\u00fcggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garc\u00eda-Sanz R, van Krieken JH, Droese J, Gonz\u00e1lez D, Bastard C, White HE, Spaargaren M, Gonz\u00e1lez M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17:2257\u20132317","journal-title":"Leukemia"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/sj.leu.2404586","volume":"21","author":"V Velden Van Der","year":"2007","unstructured":"Van Der Velden V, Cazzaniga G, Schrauder A, Hancock J, Bader P, Panzer-Grumayer E, Flohr T, Sutton R (2007) Analysis of minimal residual disease by Ig\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia 21:604\u2013611","journal-title":"Leukemia"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0167-5699(00)01650-9","volume":"21","author":"K Stamatopoulos","year":"2000","unstructured":"Stamatopoulos K, Kosmas C, Belessi C, Stavroyianni N, Kyriazopoulos P, Papadaki T (2000) Molecular insights into the immunopathogenesis of follicular lymphoma. Immunol Today 21:298\u2013305","journal-title":"Immunol Today"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/(SICI)1098-2264(199801)21:1<17::AID-GCC4>3.0.CO;2-B","volume":"21","author":"T Akasaka","year":"1998","unstructured":"Akasaka T, Yonetani N, Ohno H, Yamabe H, Fukuhara S, Okuma MAH (1998) Refinement of the BCL2\/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets. Genes Chromosomes Cancer 21:17\u201329","journal-title":"Genes Chromosomes Cancer"},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/sj.leu.2401889","volume":"14","author":"G Buchonnet","year":"2000","unstructured":"Buchonnet G, Lenain P, Ruminy P, Lepretre S, Stamatoullas A, Parmentier F, Jardin F, Duval C, Tilly H, Bastard C (2000) Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3\u2032 BCL2 breakpoints and evidence of a new cluster. Leukemia 14:1563\u20131569","journal-title":"Leukemia"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/sj.leu.2402568","volume":"16","author":"G Buchonnet","year":"2002","unstructured":"Buchonnet G, Jardin F, Jean N, Bertrand P, Parmentier F, Tison S, Lepretre S, Contentin N, Lenain P, Stamatoullas-Bastard A, Tilly H, Bastard C (2002) Distribution of BCL2 breakpoints in follicular lymphoma and correlation with clinical features: specific subtypes or same disease? Leukemia 16:1852\u20131856","journal-title":"Leukemia"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"9638","DOI":"10.1073\/pnas.88.21.9638","volume":"88","author":"CL Rosenberg","year":"1991","unstructured":"Rosenberg CL, Wong E, Petty EM, Bale AE, Tsujimoto Y, Harris NL, Arnold A (1991) PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 88:9638\u20139642","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR29","first-page":"3243","volume":"51","author":"M Kneba","year":"1991","unstructured":"Kneba M, Eick S, Herbst H, Willigeroth S, Pott C, Bolz I, Bergholz M, Neumann C, Stein H, Krieger G (1991) Frequency and structure of t(14;18) major breakpoint regions in non-Hodgkin\u2019s lymphomas typed according to the Kiel classification: analysis by direct DNA sequencing. Cancer Res 51:3243\u20133250","journal-title":"Cancer Res"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/sj.leu.2401172","volume":"12","author":"C Pott","year":"1998","unstructured":"Pott C, Tiemann M, Linke B, Ott MM, von Hofen M, Bolz I, Hiddemann W, Parwaresch R, Kneba M (1998) Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas. Leukemia 12:1630\u20131637","journal-title":"Leukemia"},{"key":"9_CR31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1182\/blood.V78.2.493.493","volume":"78","author":"ME Williams","year":"1991","unstructured":"Williams ME, Meeker TC, Swerdlow SH (1991) Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes. Blood 78:493\u2013498","journal-title":"Blood"},{"key":"9_CR32","first-page":"5541s","volume":"52","author":"ME Williams","year":"1992","unstructured":"Williams ME, Swerdlow SH, Rosenberg CL, Arnold A (1992) Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma. Cancer Res 52:5541s\u20135544s","journal-title":"Cancer Res"},{"key":"9_CR33","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.exphem.2006.08.008","volume":"34","author":"M Ladetto","year":"2006","unstructured":"Ladetto M, Mantoan B, De Marco F, Drandi D, Aguzzi C, Astolfi M, Vallet S, Ricca I, Aquila MD, Pagliano G, Monitillo L, Pollio B, Santo L, Cristiano C, Rocci A, Francese R, Bodoni CL, Borchiellini A, Schinco P, Boccadoro M, Tarella C (2006) Cells carrying nonlymphoma-associated bcl-2\/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations. Exp Hematol 34:1680\u20131686","journal-title":"Exp Hematol"},{"key":"9_CR34","unstructured":"van der Velden VHJ, van Dongen JJ (2009) MRD detection in acute lymphoblastic leukemia patients using Ig\/TCR gene rearrangements as targets for real-time quantitative PCR In: Walker J (ed) Methods in Molecular Biology. Humana Press A Part of Springer Science and Media, New York, pp 115\u2013150"},{"key":"9_CR35","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJ Dongen van","year":"2003","unstructured":"van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, van Krieken JH, Droese J, Gonzalez D, Bastard C, White HE, Spaargaren M, Gonzalez M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17:2257\u20132317","journal-title":"Leukemia"},{"key":"9_CR36","first-page":"162","volume":"26","author":"C Pott","year":"2003","unstructured":"Pott C, Schrader C, Trautmann H, Irmer S, Desgranges C, Ritgen M, Siebert R, Harder S, Unterhalt M, Hiddemann W, Hansmann ML, Parwaresch MR, Kneba M (2003) VH mutational status and VH gene usage define molecular heterogeneity in mantle cell lymphoma. Onkologie 26:162","journal-title":"Onkologie"},{"key":"9_CR37","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-2141.2012.09161.x","volume":"158","author":"E Gimenez","year":"2012","unstructured":"Gimenez E, Chauvet M, Rabin L, Puteaud I, Duley S, Hamaidia S, Bruder J, Rolland-Neyret V, Le Gouill S, Tournilhac O, Voog E, Maisonneuve H, Jacob MC, Leroux D, B\u00e9n\u00e9 MC, Formisano-Tr\u00e9ziny C, Gabert J, Gressin R, Callanan MB (2012) Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d\u2019Etude des Leuc\u00e9mies et Autres Maladies du Sang. Br J Haematol 158:186\u2013197","journal-title":"Br J Haematol"},{"key":"9_CR38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/leu.2009.268","volume":"24","author":"M Br\u00fcggemann","year":"2010","unstructured":"Br\u00fcggemann M, Schrauder A, Raff T, Pfeifer H, Dworzak M, Ottmann OG, Asnafi V, Baruchel A, Bassan R, Benoit Y, Biondi A, Cav\u00e9 H, Dombret H, Fielding AK, Fo\u00e0 R, G\u00f6kbuget N, Goldstone AH, Goulden N, Henze G, Hoelzer D, Janka-Schaub GE, Macintyre EA, Pieters R, Rambaldi A, Ribera J-MM, Schmiegelow K, Spinelli O, Stary J, von Stackelberg A, Kneba M, Schrappe M, van Dongen JJM, Bruggemann M, Schrauder A, Raff T, Pfeifer H, Dworzak M, Ottmann OG, Asnafi V, Baruchel A, Bassan R, Benoit Y, Biondi A, Cave H, Dombret H, Fielding AK, Foa R, Gokbuget N, Goldstone AH, Goulden N, Henze G, Hoelzer D, Janka-Schaub GE, Macintyre EA, Pieters R, Rambaldi A, Ribera J-MM, Schmiegelow K, Spinelli O, Stary J, Von SA, Kneba M, Schrappe M, van Dongen JJM (2010) Standardized MRD quantification in European ALL trials: proceedings of the second international symposium on MRD assessment in Kiel, Germany, 18\u201320 September 2008. Leukemia 24:521\u2013535","journal-title":"Leukemia"},{"key":"9_CR39","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1182\/blood-2005-07-2708","volume":"107","author":"M Bruggemann","year":"2006","unstructured":"Bruggemann M, Raff T, Flohr T, Gokbuget N, Nakao M, Droese J, Luschen S, Pott C, Ritgen M, Scheuring U, Horst HA, Thiel E, Hoelzer D, Bartram CR, Kneba M (2006) Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. Blood 107:1116\u20131123","journal-title":"Blood"},{"key":"9_CR40","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1073\/pnas.95.4.1460","volume":"95","author":"J SantaLucia","year":"1998","unstructured":"SantaLucia J (1998) A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. Proc Natl Acad Sci USA 95:1460\u20131465","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR41","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0002-9440(10)64905-X","volume":"160","author":"A Albinger-Hegyi","year":"2002","unstructured":"Albinger-Hegyi A, Hochreutener B, Abdou M-TT, Hegyi I, Dours-Zimmermann MT, Kurrer MO, Heitz PU, Zimmermann DR (2002) High frequency of t(14;18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas: improved polymerase chain reaction protocols for their detection. Am J Pathol 160:823\u2013832","journal-title":"Am J Pathol"},{"key":"9_CR42","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1038\/sj.leu.2401246","volume":"12","author":"MJ Pongers-Willemse","year":"1998","unstructured":"Pongers-Willemse MJ, Verhagen OJ, Tibbe GJ, Wijkhuijs AJ, de Haas V, Roovers E, van der Schoot CE, van Dongen JJ (1998) Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia 12:2006\u20132014","journal-title":"Leukemia"},{"key":"9_CR43","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/sj.leu.2404586","volume":"21","author":"VHJ Velden van der","year":"2007","unstructured":"van der Velden VHJ, Cazzaniga G, Schrauder A, Hancock J, Bader P, Panzer-Grumayer ER, Flohr T, Sutton R, Cave H, Madsen HO, Cayuela JM, Trka J, Eckert C, Foroni L, Zur Stadt U, Beldjord K, Raff T, van der Schoot CE, van Dongen JJM (2007) Analysis of minimal residual disease by Ig\/\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia 21:604\u2013611","journal-title":"Leukemia"},{"key":"9_CR44","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1046\/j.1365-2141.2002.03641.x","volume":"118","author":"KE Summers","year":"2002","unstructured":"Summers KE, Davies AJ, Matthews J, Jenner MJ, Cornelius V, Amess JA, Norton AJ, Rohatiner AZ, Fitzgibbon J, Lister TA, Goff LK (2002) The relative role of peripheral blood and bone marrow for monitoring molecular evidence of disease in follicular lymphoma by quantitative real-time polymerase chain reaction. Br J Haematol 118:563\u2013566","journal-title":"Br J Haematol"},{"key":"9_CR45","doi-asserted-by":"crossref","first-page":"abstract 623","DOI":"10.1182\/blood.V128.22.613.613","volume":"128","author":"C Pott","year":"2016","unstructured":"Pott C, Hoster E, Kehden B, Unterhalt M, Herold M, van der Jagt R, Janssens A, Kneba M, Mayer M, Pocock C, Danesi N, Fingerle-Rowson G, Harbron C, Mundt K, Marcus RE, Hiddemannnn W (2016) Minimal residual disease in patients with follicular lymphoma treated with Obinutuzumab or Rituximab as first-line induction immunochemotherapy and maintenance in the phase 3 GALLIUM study. Blood 128:abstract 623","journal-title":"Blood"}],"container-title":["Methods in Molecular Biology","Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9151-8_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T02:27:23Z","timestamp":1606530443000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9151-8_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493991501","9781493991518"],"references-count":45,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9151-8_9","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"19 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}